Back to mobile site

BioCryst Pharma (BCRX) Posts Narrower than Expected Q4 Loss

February 10, 2011 6:47 AM EST Send to a Friend
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login